Pushing the boundaries of 21st century pharmaceuticals through targeted delivery systems
SMi’s 8th annual RNA Therapeutics conference will feature a mix of case study-led presentations, panel debates, interactive workshops and keynote addresses tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems.
The programme for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing.
Join to expand your scientific horizons on emerging concepts in nanoparticle delivery systems, small activating RNA and 3rd generation antisense technology. Under-met areas such as targeted delivery beyond the liver will be addressed and regulatory guidance on the reporting of clinical data through an exclusive MHRA keynote will be offered.
See the full program here
Featured speakers include:
Reasons to attend RNA Therapeutics 2017: